ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

An Analysis of Factors Associated with Pancreas Allograft Thrombosis.

J. Steggerda, K. Bornhurst, A. Annamalai, A. Peng, J. Mirocha, D. Dafoe.

Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.

Meeting: 2016 American Transplant Congress

Abstract number: A71

Keywords: Pancreas transplantation, Survival

Session Information

Date: Saturday, June 11, 2016

Session Name: Poster Session A: Clinical Pancreas Transplantation and All Islet Cell Transplantation Topics

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Halls C&D

Related Abstracts
  • Management of Pancreas Graft Splenic Vein Thrombosis: Is Conservative Management Safe?
  • Mechanical Thrombectomy for the Treatment of Pancreas Transplant Venous Thrombosis: A Single Center Experience.

A successful simultaneous pancreas-kidney (SPK) transplant in recipients with end-stage diabetic nephropathy will provide normoglycemia and exert a salutary effect on neurovascular complications. Early, non-technical thrombosis is the main cause of pancreas allograft loss.

The objective of our study was to identify factors associated with pancreas graft thrombosis.

An analysis of variables (donor, recipient, post-operative) was carried out on 71 SPK transplants performed from 2005-2015 to identify correlates of graft thrombosis. The database was composed of Era 1 (n=46) and Era 2 (n=25) defined by a distinct change in protocol. The Era 2 protocol entailed less aggressive fluid replacement (not driven by a CVP target of 10-12) and a single intraoperative loading dose of heparin.

The primary outcome evaluated was pancreas graft thrombosis at 30 days.

The following variables were associated with pancreas graft thrombosis as compared to surviving grafts: net intake and output (I&O) during surgery (mean 7,500 vs. 4,169 cc, P=0.0001) and net I&O in the first 24 hours (10,700 vs. 7,136 cc, P=0.003) and need for vasopressors (P=0.034). Heparin administration (P=0.009) correlated with freedom from thrombosis and the addition of aspirin nearly achieved significance, (P=0.056). The number of thromboses differed significantly in Era 1 (8/46) vs. Era 2 (0/25), P=0.044. Our latest SRTR report showed 100% 1 year patient and kidney graft survival with no Era 2 pancreas graft losses.

Conclusions: Judicious perioperative fluid replacement, avoidance of vasopressors and a single dose of heparin appeared to be protective against pancreas graft thrombosis.

CITATION INFORMATION: Steggerda J, Bornhurst K, Annamalai A, Peng A, Mirocha J, Dafoe D. An Analysis of Factors Associated with Pancreas Allograft Thrombosis. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Steggerda J, Bornhurst K, Annamalai A, Peng A, Mirocha J, Dafoe D. An Analysis of Factors Associated with Pancreas Allograft Thrombosis. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/an-analysis-of-factors-associated-with-pancreas-allograft-thrombosis/. Accessed February 25, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Home
  • Search
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.